Human placental ex vivo studies to support an adenovirus-mediated vascular endothelial growth factor (VEGF) gene medicine for the treatment of severe early onset fetal growth restriction (FGR)

    Research output: Contribution to journalMeeting Abstractpeer-review

    Original languageEnglish
    Pages (from-to)A60-A60
    Number of pages1
    JournalHuman Gene Therapy
    Volume25
    Issue number11
    Publication statusPublished - 1 Nov 2014

    Cite this